Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕Franklin Asian Equity Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundFranklin Asian Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataFranklin
NAV₹40.2296₹45.3436
NAV date20 Nov 202619 Nov 2026
History10.9 years13.9 years
Expense ratio1.1%1.2%
Stars★★★★★★★★★★
Growth Score67.5065.10

Returns

Tata India Pharma & Healthcare FundFranklin Asian Equity Fund
1 month+9.87%−1.78%
3 months+1.12%−8.66%
6 months+7.63%−3.66%
YTD+13.73%+16.21%
1 year+11.82%+20.98%
3 years (CAGR)+18.74%+19.44%
5 years (CAGR)+16.00%+6.81%
10 years (CAGR)+15.95%+10.32%
Since launch+13.58%+9.32%

Risk

Tata India Pharma & Healthcare FundFranklin Asian Equity Fund
Volatility15.7%17.7%
Downside volatility10.0%10.4%
Sharpe0.780.73
Sortino1.231.25
Calmar1.121.37
Return / risk1.191.10
Deepest fall−19.84%−40.20%
Days to recover3751074
Below its high+0.00%−11.70%

Against benchmark

Tata India Pharma & Healthcare FundFranklin Asian Equity Fund
Alpha−2.76%+10.56%
Beta1.000.51
R²90.2%21.3%
Up capture91.7%69.9%
Down capture101.4%1.9%
Tracking error4.9%17.6%
Information ratio−0.570.45
Treynor0.110.26

Consistency

Tata India Pharma & Healthcare FundFranklin Asian Equity Fund
Best 1-year+76.35%+71.57%
Middle 1-year+8.85%+10.63%
Worst 1-year−17.32%−32.93%
1-year periods with a loss29.0%26.1%
Middle 3-year+21.13%+8.99%
Positive months63.9%58.3%
Best day+3.34%+5.04%
Worst day−3.09%−6.66%
Worst 5% day−1.35%−1.67%
Positive days55.4%56.9%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundFranklin Asian Equity Fund
5-year XIRR+18.07%+15.08%
5-year value₹9,50,065₹8,81,338
3-year XIRR+13.31%+19.77%
1-year XIRR+18.41%+4.81%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth